Connect with us

Hi, what are you looking for?

Saturday, Dec 2, 2023
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.


Why Ohio Could be a Key State for Progressing Medical Marijuana

Ohio has been altering its legal status on medical marijuana by adding autism and anxiety as two new conditions legal medical cannabis can treat

The Medical Board of Ohio looked at adding five medical conditions to its list of 21 ailments that can be treated with medical marijuana legally. The list included depression, insomnia, anxiety, autism, and opioid use disorder. But the panel decided May 8 only autism and anxiety can be officially added.

The verdict was a blow for recovering opioid addicts, but Tess Pollock, spokeswoman for the board, told reporters “treating addiction should not be confused with using medical marijuana to treat pain.”

Since the Buck Eye state opened legal medical pot dispensaries on Jan. 1, more than 30,000 patients registered with sales surpassing US$5.8 million.

Currently, there are a total of 33 states that have medical marijuana programs that vary state by state in what ailments can be treated. Ohio has been one of the more lenient States on qualifying conditions and analysis found nearly one-third of residents in the state would qualify for medical cannabis use based on the conditions that are already approved. That’s approximately 3.5 million patients.

However, medical marijuana requires more clinical research, the state’s panel concluded. The legal status of the drug and lack of concrete findings has made it an uphill battle convincing regulators, doctors and patients about its effectiveness.

Why Ohio Could Prove to be Important for the U.S. Cannabis Market

Clinical researchers and citizens are thirsty for knowledge on pot’s effectiveness in treating conditions and its side effects. But only recently some conditions are being approved for medical marijuana use, which could help health officials collect data. So far, most experts are wary of the endless anecdotal evidence surrounding cannabis.  Some physicians and researchers have called for marijuana to be removed Schedule I classification, because the status makes it nearly impossible to conduct extensive research. But with more states accepting medical pot to treat certain ailments, more data can be collected to look at its health benefits.

Ohio is noted as the test market of the U.S., and with easing laws on medical marijuana it could help aid more research on THC, CBD, and other cannabinoids. Studies so far have been minimal, but there have been signs of its effectiveness. One study involved looking at over 400 individuals and found that consumption of cannabis was associated with “significant improvements in perceived insomnia.”

Another study involving depression, which was removed in Ohio’s list of treatable conditions for medical marijuana, also saw a decrease in symptoms and was particularly helpful for women. The study went into specifics of depression treatments that researchers hadn’t seen before:

This is to my knowledge one of the first scientific studies to provide guidance on the strains and quantities of cannabis people should be seeking out for reducing stress, anxiety and depression.

– Carrie Cuttler, clinical assistant professor of psychology at Washington State University


Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like


All participants in the placebo group reported a 50 per cent drop in depression symptoms after surgery


'This will be the first new U.S.-owned uranium enrichment plant to begin production since 1954,' says the company's CEO


It found that 75 per cent of patients saw a significant decrease in their self-reported illness severity


Poor mental health affects not only quality of life but performance, resilience and career trajectories of athletes